信邦制药(002390.SZ)发布前三季度业绩，归母净利润1.52亿元，同比下降13.74%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved operating revenue of 4.266 billion yuan, representing a year-on-year decrease of 6.55% [1] - The net profit attributable to shareholders of the listed company was 152 million yuan, down 13.74% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 157 million yuan, reflecting a year-on-year decline of 10.50% [1]